• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
193.062981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
51.34
13643
EPS(TTM)
Face Value()
Div & Yield %
25.4
1
0.58
 

franklin industries ltd
Franklin Industries reports standalone net loss of Rs 11.06 crore in the March 2026 quarter
May 20,2026
Net Loss of Franklin Industries reported to Rs 11.06 crore in the quarter ended March 2026 as against net loss of Rs 3.47 crore during the previous quarter ended March 2025. Sales declined 93.03% to Rs 6.37 crore in the quarter ended March 2026 as against Rs 91.37 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 18.62 crore in the year ended March 2026 as against net profit of Rs 11.16 crore during the previous year ended March 2025. Sales declined 85.59% to Rs 25.25 crore in the year ended March 2026 as against Rs 175.24 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.3791.37 -93 25.25175.24 -86
OPM %-173.00-3.83 --73.706.37 -
PBDT-11.00-3.46 -218 -18.5411.21 PL
PBT-11.01-3.47 -217 -18.5711.18 PL
NP-11.06-3.47 -219 -18.6211.16 PL